Search Results 1101-1110 of 38057 for Two-phase

  1. Clinical trials - Oncology (Medical)

    This partially randomized phase III trial studies the side effects of ... In Part 2, the step-up dose identified in Part 1 will be used followed by ...

  2. A Phase 1 Study Evaluating the Safety, PK, and Clinical Effects of PT-112 in Subjects With Advanced Solid Tumors

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  3. A Study of LNK01002 in Patients With Primary (PMF) or Secondary Myelofibrosis (PV-MF, ET-MF) or Acute Myeloid Leukemia - Mayo Clinic

    Study phase. 1. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  4. Symptoms and causes - Mayo Clinic

    Stage 1, 90 or above, Healthy kidney function. Stage 2, 60 to 89, Mild loss of kidney function. Stage 3a, 45 to 59, Mild to moderate loss of kidney function.

  5. Clinical trials - Oncology (Medical)

    ... phase 2 dose (RP2D) 1.1.2 To evaluate the safety and tolerability of this ... In Part 2, the step-up dose identified in Part 1 will be used followed by ...

  6. A Study to Evaluate Effectiveness of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH) - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  7. Study of ORIC-533 in Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    About this study. The purpose of this study is to establish the Recommended Phase 2 Dose (RP2D), safety, pharmacokinetics (PK), pharmacodynamics (PD), ...

  8. A Study to Evaluate LY3484356 Alone or Combined with Anticancer Therapies to Treat Patients with Breast or Endometrial Cancer - Mayo Clinic

    The purpose of this study is to identify the recommended Phase 2 dose (RP2D) of LY3484356 administered as monotherapy and in combination with other anticancer ...

  9. ICoN-1 Phase 3 Study Of The Efficacy And Safety Of Treatment With MNKD-101, Clofazimine Inhalation Suspension - Mayo Clinic

    Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  10. Phase IIb Study of Dasatinib Versus Imatinib in Patients With CML-CP Who Have Not Achieved an Early Optimal Response to Imatinib - Mayo Clinic

    Study phase. 2/3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...